Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region.

Chao Tian TangEe Cheong ChuaQian Hui ChewYan-Ling HeTian-Mei SiHelen F-K ChiuYu-Tao XiangTakahiro A KatoShigenobu KanbaNaotaka ShinfukuMin-Soo LeeSeon-Cheol ParkYong-Chon ParkMian-Yoon ChongShih-Ku LinShu-Yu YangAdarsh TripathiAjit AvasthiSandeep GroverRoy A KallivayalilPichet UdomratnKok Yoon CheeAndi J TanraMd Golam RabbaniAfzal JavedSamudra KathiarachchiDulshika WaasWing Aung MyintNorman SartoriusVan Cuong TranKim Viet NguyenChay-Hoon TanRoss J BaldessariniKang Sim

Published in: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists (2020)

These findings behoove clinicians to be mindful when evaluating patients' need to be on LAI antipsychotics amidst multifaceted considerations, especially downstream adverse events such as metabolic and extrapyramidal side effects.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
bipolar disorder
prognostic factors
tissue engineering